ArticleWellcome open research2023

Five-alpha reductase inhibitors and risk of prostate cancer among men with benign prostatic hyperplasia: A historical cohort study using primary care data.

Dixa B Thakrar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.